CMND
Income statement / Annual
Last year (2025), Clearmind Medicine Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Clearmind Medicine Inc's net income was -$3.86 M.
See Clearmind Medicine Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
10/31/2025 |
10/31/2024 |
10/31/2023 |
10/31/2022 |
10/31/2021 |
10/31/2020 |
10/31/2019 |
10/31/2018 |
10/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$49.36 K
|
$51.07 K
|
$57.43 K
|
$119.62 K
|
$2.53 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$49.36 K
|
-$51.07 K
|
-$57.43 K
|
-$119.62 K
|
-$2.53 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$2.05 M
|
$1.37 M
|
$1.53 M
|
$4.42 M
|
$635.40 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.57 M
|
$4.32 M
|
$4.71 M
|
$4.47 M
|
$2.98 M
|
$230.12 K
|
$104.15 K
|
$259.19 K
|
$6.53 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$5.62 M
|
$5.69 M
|
$6.24 M
|
$8.88 M
|
$3.61 M
|
$230.12 K
|
$104.15 K
|
$259.19 K
|
$6.53 K
|
| Cost And Expenses |
$5.67 M
|
$5.74 M
|
$6.29 M
|
$9.00 M
|
$3.61 M
|
$230.12 K
|
$104.15 K
|
$259.19 K
|
$6.53 K
|
| Interest Income |
$132.90 K
|
$271.22 K
|
$59.09 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$19.54 K
|
$36.16 K
|
$0.00
|
$20.76 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$49.36 K
|
$51.07 K
|
$57.43 K
|
$119.62 K
|
$2.53 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| EBITDA |
-$3.72 M |
-$4.79 M |
-$8.53 M |
-$9.75 M |
-$3.65 M |
-$230.12 K |
-$104.15 K |
-$198.10 K |
-$6.53 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.88 M
|
$868.21 K
|
-$2.30 M
|
-$883.54 K
|
-$42.78 K
|
$0.00
|
$0.00
|
$61.10 K
|
$0.00
|
| Income Before Tax |
-$3.79 M
|
-$4.88 M
|
-$8.59 M
|
-$9.89 M
|
-$3.66 M
|
-$230.12 K
|
-$104.15 K
|
-$198.09 K
|
-$6.53 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$70.44 K
|
$377.97 K
|
$17.35 K
|
$42.99 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$3.86 M
|
-$5.25 M
|
-$8.61 M
|
-$9.93 M
|
-$3.66 M
|
-$230.12 K
|
-$104.15 K
|
-$198.09 K
|
-$6.53 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3.03 |
-6.78 |
-170.07 |
-916.44 |
-473.1 |
-50.76 |
-33.76 |
-73.5 |
-2.15 |
| EPS Diluted |
-3.03 |
-6.78 |
-170.07 |
-916.44 |
-473.1 |
-50.76 |
-33.76 |
-73.5 |
-2.15 |
| Weighted Average Shares Out |
$1.27 M
|
$775.03 K
|
$50.62 K
|
$10.83 K
|
$7.73 K
|
$4.53 K
|
$3.08 K
|
$2.69 K
|
$3.06 K
|
| Weighted Average Shares Out Diluted |
$1.27 M
|
$775.03 K
|
$50.62 K
|
$10.83 K
|
$7.73 K
|
$4.53 K
|
$3.08 K
|
$2.69 K
|
$3.06 K
|
| Link |
|
|
|
|
|
|
|
|
|
